poisar

Stocks · News reference

Longeveron Announces 1-for-10 Reverse Stock Split, Expected To Become Effective August 26

BenzingaAug 24, 2026, 8:07 PMBenzinga Newsdesk

Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company will

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 24, 2026, 8:07 PM
Checked
Aug 24, 2026, 8:07 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading